Insights
Children’s Data Security: Current Developments Worldwide and in Türkiye
In the digital ecosystem, children are no longer viewed solely as individuals in need of protection; they have also become one of the central user segments within data-driven business models. Social media platforms, gaming applications, and video-sharing websites systematically process children’s behavioral data, interaction patterns, and content consumption habits. This reality has led to a transformation in the legal approach to children’s data protection, shifting from a… »
An Assessment of the Unified Patent Court’s International Jurisdiction and the Sovereign Response of Third States in Light of Recent Case Law
The scope of the international jurisdiction of the Unified Patent Court (“UPC”) has, in recent years, become one of the most striking and controversial issues in patent litigation. Having commenced its operations in 2023, the Court was established with the objective of creating a uniform and centralized patent adjudication system across Europe. However, through its recent decisions, the UPC appears not to confine its jurisdiction to Contracting Member States alone, but rather… »
Recent Changes Regarding the Determination of Companies Subject to Independent Auditing
The Decision Amending the Decision on Determination of Companies Subject to Independent Auditing ("Amendment Decision") was published in the Official Gazette dated March 17, 2026. With the Amendment Decision, which entered into force as of its publication date to be applied to accounting periods starting on or after 1 January 2026, companies that are not included in the lists (I) and (II) annexed to the Decision on the Determination of Companies Subject to Independent Audit… »
On the Court of Cassation’s “My Sweet Orange Tree” Decision
The legal nature of translations represents an important issue under copyright law. Indeed, a translation is often not simply a technical transfer between languages; particularly in the context of literary works, it constitutes the product of intensive intellectual labor whereby the translator reconstructs the work by drawing on the culture of the target language, its expressive possibilities, and the translator’s own interpretation. In this respect, a translation may in… »
A New Era in the Pricing of Human Medicinal Products: Euro Exchange Rate Increased to 65% of the Previous Year’s Average, Pricing Incentive Introduced for the First Equivalent/Generic Product
Presidential Decision No. 11031 dated 12 March 2026 (“New Pricing Decision”) has introduced significant changes to the pricing system for human medicinal products that was originally established by Decision No. 2017/9901 and subsequently updated several times. Increasing the adjustment rate used in Euro/TL calculations from 60% to 65%, allowing higher pricing for the first equivalent or generic products to encourage their faster entry into the market, and the inclusion for… »
Court of Cassation Confirms Binding Effect of Agreements Between Parties in Trademark Invalidation Claims
The plaintiff consented to the defendant’s trademark under an agreement but later sought invalidation of the earlier-filed trademark. The Court of Cassation held that the agreement covered the earlier trademark based on the parties’ actual and implied intentions. Filing an invalidation action despite prior consent was found to be contrary to the principle of good faith. In Decision No. 2025/2697 E, 2025/6214 K of 13 October 2025, the Court of Cassation (CoC) upheld the… »
Insurance Litigation 2026 in Turkey
Legal and procedural framework Legal framework What legal framework applies to insurance coverage disputes, including legislation or judicial precedents? 08 December 2025Insurance coverage disputes in Türkiye are primarily governed by the Turkish Commercial Code (Law No. 6102) (TCC) (articles 1401to1520) and the Insurance Act (Law No. 5684), which regulate insurance contracts, coverage limits, exclusions, duties of disclosure and the authority of the Insurance Arbitration… »
The NIVEA Blue Effect: Can Increased Distinctiveness Create Likelihood of Confusion Based on Common Colours?
Higher Board of the Turkish Patent and Trademark Office upheld Beiersdorf’s opposition against a later trademark sharing NIVEA's distinctive blue-and-white composition The Board highlighted the later mark could cause a likelihood of confusion with NIVEA, give the earlier’s strong distinctiveness and recognisability from its blue and white colour scheme This precedent confirms colour and composition similarities can be decisive in trademark disputes when earlier marks have… »
Termination of Employment Contract Due to an Employee’s Frequent Medical Reports
The frequent and prolonged medical leave taken by an employee often adversely affects the normal functioning of the workplace and renders the continuation of the employment relationship challenging. Such persistent absenteeism may lead the employer to terminate the employment contract on the grounds of either just cause or a valid reason. Pursuant to Article 18 of the Labor Act No. 4857, the employment contract of an employee benefiting from job security provisions may be… »
A New Decision of The Constitutional Court on The Turkish Competition Board’s on-site Inspections
One of the most debated issues in Turkish competition law in 2023 was the decision of the Constitutional Court dated 23 March 2023 (Application No. 2019/40991), in which the Court held that the on-site inspection conducted at the premises of Ford Otomotiv Sanayi A.Ş. violated the constitutional right to the immunity of residence due to its unlawfulness. Following that decision, significant uncertainty arose as to whether the legislature would amend the relevant statutory… »
New Real-World Data and Pharmacoeconomic Studies for NPP Products
On 19 January 2026, the Turkish Medicines and Medical Devices Agency announced a new initiative focusing on real-world data and pharmacoeconomic analyses for medicines supplied from abroad within the scope of named patient programs. The initiative applies to medicines obtained under the regulation governing the supply of medicines from outside Türkiye, which are typically used in situations where no authorized or available alternative exists in the domestic market and access… »
News and Events
Gün + Partners Ranked in the IAM Patent 1000 - The World's Leading Patent Professionals 2025
The 2025 edition of the IAM Patent 1000: The World’s Leading Patent Professionals has been released. We are proud to announce that we have been recognised as the top tier firm and our 8 practitioners are recognized as the leading individuals in the IAM Patent 1000 - The World's Leading Patent Professionals 2025. The IAM Patent 1000: The World’s Leading Patent Professionals is a comprehensive guide to top private practice patent experts and expert witnesses worldwide, based…
Mehmet Gün Listed in IAM Strategy 300 2026
We’re proud to share that Mehmet Gün has been recognized in the IAM Strategy 300: The World’s Leading IP Strategists 2026. This prestigious list highlights individuals who are shaping the future of IP through innovative and high-impact portfolio strategies. The IAM Strategy 300 identifies global leaders who excel at developing and implementing approaches that unlock the full value of intellectual property.
We Attended the INTA 2025 Policy Dialogue Panel
“INTA 2025 Policy Dialogue: Intellectual Property Rights and the Protection of Public Health: From Counterfeit/Falsified Medicines to Data Exclusivity” panel was held on 24 November 2025, hosted by the International Trademark Association (INTA) and the Association of Research-Based Pharmaceutical Companies (AİFD). The opening remarks were delivered by Uğur Aktekin, our partner and a member of INTA’s Famous and Well-Known Marks Committee. The session “Combating…
Our 2025-2026 Legal Trainees Joined Us
We are pleased to announce that our 2025–2026 legal trainee associates have just commenced their traineeship following successful completion of their exams. We wholeheartedly congratulate and welcome them on board!
2025 Policy Dialogue: Safeguarding Intellectual Property Rights & Public Health
Explore the intersection of intellectual property (IP) and the pharmaceutical sector at the upcoming 2025 Policy Dialogue: Safeguarding Intellectual Property Rights & Public Health: From Falsified/Counterfeit Medicines to Data Exclusivity, taking place in Istanbul on November 24, 2025. This in-person event, hosted by INTA and the Association of Research-Based Pharmaceutical Companies (AIFD), brings together industry leaders, government officials, and legal experts for…
Uğur Aktekin Moderated the Panel on Well-Known Marks, and Pınar Arıkan Moderated the Panel on Nontraditional Marks at the INTA Policy Dialogue in Istanbul
The 2024 Policy Dialogue: Well-Known Marks and Nontraditional Trademarks in Türkiye, organized by the International Trademark Association (INTA), was successfully hosted at İstanbul Bilgi University. The event featured a series of insightful discussions focused on critical issues in trademark protection. The event started with the opening remarks of Tat Louembe and Gül Okutan Nilsson and followed by the keynote speech of Güler Ayyıldız Dalma. The first panel, titled…
Dicle Doğan to Speak at ARTED’s “Anti-Corruption and Interactions with Healthcare Professionals” Training
Our Managing Associate Dicle Doğan, who spoke at the first session of the “Anti-Corruption and Interactions with Healthcare Professionals” training held on November 11, 2025, will once again take part as a speaker on December 2, 2025. The training will serve as an important platform for strengthening ethical standards and fostering transparent and trustworthy relationships across the sector. Participants will gain valuable insights into practical strategies and ethical…
Mehmet Gün, Özge Atılgan Karakulak and Selin Sinem Erciyas are Listed in IAM Global Leaders 2026
We are pleased to announce that our founding partner Mehmet Gün and partners Özge Atılgan Karakulak and Selin Sinem Erciyas, have been recognized as IAM Global Leaders for the year 2026. This prestigious distinction is reserved for individuals who attain the gold tier ranking in the IAM Patent 1000, an authoritative directory that identifies the foremost law firms and attorneys in key patent jurisdictions around the world. This recognition reflects our firm’s commitment to…
Our Lawyers Have Been Recognised as Mondaq Thought Leading Authors Autumn 2025
We are delighted our lawyers have been recognised as Mondaq Thought Leading Authors for the below categories at the Mondaq Autumn 2025 awards. Environmental Law - Eco-Friendly Or Eco-Fiction?Finance & Banking - Amendments to the Insurance Agencies RegulationFood, Drugs, Healthcare, Life Sciences - Notification Obligation in Case of Supply Interruption of Medical DevicesIntellectual Property - The Role of Artificial Intelligence in Trademark EnforcementMedia, Telecoms…
Begüm Yavuzdoğan Okumuş and Yalçın Umut Talay Will Be Attending IAPP Europe Data Protection Congress 2025
We are pleased to announce our participation at the IAPP Europe Data Protection Congress 2025, which will be held in Brussels on 19-20 November 2025 and extend an invitation for a potential meeting during the event. Representing our TMT and Data Protection & Privacy practices, Begüm Yavuzdoğan Okumuş, partner, and Yalçın Umut Talay, managing associate, will be attending the conference. If you are interested in exploring collaboration opportunities or simply reconnecting…
Mehmet Gün and Selin Sinem Erciyas Will Speak in the “Frontier Technologies, Innovation, and Intellectual Property” Conference in Ankara
We are pleased to announce that our Senior Partner Mehmet Gün and Partner Selin Sinem Erciyas will be speaking in the Conference on “Frontier Technologies, Innovation, and Intellectual Property,” held at the METU Culture and Convention Center in Ankara, Türkiye, on November 3–4, 2025. Mehmet Gün will moderate the session “The Future of Intellectual and Industrial Property: The Post-Patent World,” where Selin Sinem Erciyas will join as a speaker. This international gathering…
Beril Yayla Sapan Delivered a Training Session at TEİD Academy
Our Partner and TEID Board Member, Beril Yayla Sapan, delivered a training session titled “Mobbing, Labor Law Practices, and Ethics” as part of the 18th Term of TEID Academy’s “Corporate Ethics and Compliance Management” Program.